A prospective trial of volumetric intensity-modulated arc therapy vs conventional intensity modulated radiation therapy in advanced head and neck cancer

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Clin Oncol. Apr 10, 2012; 3(4): 57-62
Published online Apr 10, 2012. doi: 10.5306/wjco.v3.i4.57

Table 1 Critical structure dose tolerances

Critical structure/organ at risk	Dose (Gy)
Ant tongue (1/2 or 1/3)	70
Brainstem	54
Brain - 50%	54
Brachial plexus	60
Spinal cord	45
Cochlea	30
Parotid – 50%	30

Citation: Fung-Kee-Fung SD, Hackett R, Hales L, Warren G, Singh AK. A prospective trial of volumetric intensity-modulated arc therapy vs conventional intensity modulated radiation therapy in advanced head and neck cancer. World J Clin Oncol 2012; 3(4): 57-62
URL: https://www.wjgnet.com/2218-4333/full/v3/i4/57.htm
DOI: https://dx.doi.org/10.5306/wjco.v3.i4.57

Fung-Kee-Fung SD, Hackett R, Hales L, Warren G, Singh AK. A prospective trial of volumetric intensity-modulated arc therapy vs conventional intensity modulated radiation therapy in advanced head and neck cancer. World J Clin Oncol 2012; 3(4): 57-62 [PMID: 22553505 DOI: 10.5306/wjco.v3.i4.57]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.